oral QD myosin inhibitor (IC50 = 1.4 µM) Ph. II candidate for cardiomyopathy (5-30 mg) from HTS w/ bovine cardiac muscle myofibrils Journal of Medicinal Chemistry Cytokinetics, South San Francisco, CA